Major Histocompatibility Complex class I and II peptide-binding groove (MHC groove)

The Major Histocompatibility Complex (MHC) peptide-binding groove is a specialized structural domain located on the surface of antigen-presenting cells (APCs), formed by the folding of MHC class I or class II protein chains. Its primary biological function is to capture and display short peptide fragments, derived from either intracellular or extracellular proteins, to T-cell receptors (TCRs) to initiate an adaptive immune response (StatPearls, 2023). MHC class I molecules present endogenous antigens to CD8+ cytotoxic T cells, while MHC class II molecules present exogenous antigens to CD4+ helper T cells (NIH, 2022). This interaction is fundamental for the recognition of pathogens and the maintenance of self-tolerance. In many autoimmune diseases, specific HLA alleles possess grooves that preferentially bind self-peptides, triggering an aberrant immune attack (PubMed, 2020). Therapeutic interventions targeting the MHC groove include peptide mimetics like glatiramer acetate, which competitively occupies the groove to prevent the presentation of autoantigens, and cancer vaccines designed to load the groove with tumor-specific neoantigens to stimulate an anti-tumor response (PubMed, 2021).

Other names

HLA peptide-binding cleftMHC binding pocketAntigen-binding grooveMHC-peptide binding site

Competitive binding to the MHC groove to displace or prevent the binding of pathogenic self-peptides, or the delivery of specific antigenic peptides to stimulate a targeted T-cell response.